Why do we need to worry about antimicrobial resistance in the time of COVID-19?
19 June 2020
The world is struggling hard to control the COVID-19 pandemic. This is difficult as the disease is new and we do not have specific drugs and vaccines to treat it or create immunity against it. What we have in our arsenal are the existing broad-spectrum antimicrobials.
Further reading: Down to Earth
Author(s): Vibha Varshney
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!
